ACAMPA MAURIZIO
Maurizio
Acampa
Ricercatore Legge 240/10 - tempo determinato
Contacts
Teaching activities
Completion accademic year: 2023/2024
Completion accademic year: 2022/2023
Completion accademic year: 2021/2022
Completion accademic year: 2020/2021
Research
Ultime pubblicazioni:
- Lazzerini, P.E., Krishna Murthy Ginjupalli, V., Srivastava, U., Bertolozzi, I., Bacarelli, M.R., Verrengia, D., et al. (2023). Anti-Ro/SSA Antibodies Blocking Calcium Channels as a Potentially Reversible Cause of Atrioventricular Block in Adults. JACC. CLINICAL ELECTROPHYSIOLOGY. - view more
- Fusi, C., Lazzerini, P.E., Cavigli, L., Focardi, M., Acampa, M., Cameli, M., et al. (2022). Maternal Anti-Ro/SSA Autoantibodies and Prolonged PR Interval in a Competitive Athlete: Beyond Training-Induced Electrical Remodeling. JACC. CASE REPORTS, 4(17), 1098-1103 [10.1016/j.jaccas.2022.05.032]. - view more
- Lazzerini, P.E., Cantara, S., Bertolozzi, I., Accioli, R., Salvini, V., Cartocci, A., et al. (2022). Transient Hypogonadism Is Associated With Heart Rate-Corrected QT Prolongation and Torsades de Pointes Risk During Active Systemic Inflammation in Men. JOURNAL OF THE AMERICAN HEART ASSOCIATION. CARDIOVASCULAR AND CEREBROVASCULAR DISEASE, 11(1) [10.1161/JAHA.121.023371]. - view more
- Kimura, S., Toyoda, K., Yoshimura, S., Minematsu, K., Yasaka, M., Paciaroni, M., et al. (2022). Practical "1-2-3-4-Day" Rule for Starting Direct Oral Anticoagulants After Ischemic Stroke With Atrial Fibrillation: Combined Hospital-Based Cohort Study. STROKE, 53(5), 1540-1549 [10.1161/STROKEAHA.121.036695]. - view more
- Lazzerini, P.E., Accioli, R., Acampa, M., Zhang, W., Verrengia, D., Cartocci, A., et al. (2022). Interleukin-6 Elevation Is a Key Pathogenic Factor Underlying COVID-19-Associated Heart Rate-Corrected QT Interval Prolongation. FRONTIERS IN CARDIOVASCULAR MEDICINE, 9, 893681 [10.3389/FCVM.2022.893681]. - view more